Optimeos Life Sciences, a startup founded by two Princeton University faculty members, has reached agreements with six pharmaceutical companies to develop therapeutics using a Princeton-developed drug delivery technology. The partnerships have the potential to improve the effectiveness of medications for the treatment of diseases, ranging from cancer to diabetes. https://engineering.princeton.edu/news/2020/02/11/it-s-all-delivery-nanoparticle-platform-could-transform-medical-treatments